M, A., K, T., M, S., K, S., J, I., J, T., & K, T. (2018, October). Utility of nintedanib for severe idiopathic pulmonary fibrosis: A single-center retrospective study. Drug Design, Development and Therapy.
Chicago Style (17th ed.) CitationM, Abe, Tsushima K, Sakayori M, Suzuki K, Ikari J, Terada J, and Tatsumi K. "Utility of Nintedanib for Severe Idiopathic Pulmonary Fibrosis: A Single-center Retrospective Study." Drug Design, Development and Therapy Oct. 2018.
MLA (9th ed.) CitationM, Abe, et al. "Utility of Nintedanib for Severe Idiopathic Pulmonary Fibrosis: A Single-center Retrospective Study." Drug Design, Development and Therapy, Oct. 2018.
Warning: These citations may not always be 100% accurate.
